Explainer: What are migraines?
If you, or someone close to you suffers from migraine, you'll know it is much more than your average headache – migraine is a debilitating disorder that can even affect your sight and speech.
Diseases, Conditions, Syndromes
Mar 14, 2013 |
5 / 5 (2) |
0
Sleepwalkers sometimes remember what they've done
Three myths about sleepwalking – sleepwalkers have no memory of their actions, sleepwalkers' behaviour is without motivation, and sleepwalking has no daytime impact – are dispelled in a recent study led by Antonio Zadra ...
Neuroscience
Mar 14, 2013 |
5 / 5 (1) |
0
No good evidence that mouthguards and helmets ward off concussion
Mouthguards and helmets can help ward off other serious head and facial injuries, but there is no good evidence that they can help prevent concussion, and paradoxically, they may even encourage players to take greater risks.
Health
Mar 11, 2013 |
not rated yet |
0
Combination therapy provides similar clinical benefit as single drug treatment in MS
People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Common MS drugs taken together do not reduce relapse risk
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Team aids discovery of first dystonia gene found in African-Americans
A pair of studies tells the tale of how a neuroscientist at Mayo Clinic in Florida helped to discover the first African-American family to have inherited the rare movement disorder dystonia, which causes repetitive muscle ...
Genetics
Mar 07, 2013 |
not rated yet |
0
|
Is this peptide a key to happiness?
(Medical Xpress)—What makes us happy? Family? Money? Love? How about a peptide? The neurochemical changes underlying human emotions and social behavior are largely unknown. Now though, for the first time in humans, scientists ...
Psychology & Psychiatry
Mar 07, 2013 |
4.9 / 5 (8) |
0
|
Research illuminates molecular mechanism for why stimulating environment may protect against Alzheimer's disease
"Use it or lose it." The saying could apply especially to the brain when it comes to protecting against Alzheimer's disease. Previous studies have shown that keeping the mind active, exercising and social interactions may ...
Alzheimer's disease & dementia
Mar 06, 2013 |
5 / 5 (5) |
0
|
Alzheimer's risk gene discovered using imaging method that screens brain's connections
(Medical Xpress)—Scientists at UCLA have discovered a new genetic risk factor for Alzheimer's disease by screening people's DNA and then using an advanced type of scan to visualize their brains' connections.
Neuroscience
Mar 06, 2013 |
not rated yet |
0
|
Cell death in retina helps tune our internal clocks
(Medical Xpress)—With every sunrise and sunset, our eyes make note of the light as it waxes and wanes, a process that is critical to aligning our circadian rhythms to match the solar day so we are alert during the day and ...
Neuroscience
Mar 05, 2013 |
5 / 5 (1) |
0
|
New effort to identify Parkinson's biomarkers
Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers—changes in the body that can be used to predict, diagnose or monitor a disease—in ...
Parkinson's & Movement disorders
Mar 05, 2013 |
5 / 5 (1) |
0
Parkinson's brain rhythms suggest better way to treat disease with deep brain stimulation
A team of scientists and clinicians at UC San Francisco has discovered how to detect abnormal brain rhythms associated with Parkinson's by implanting electrodes within the brains of people with the disease.
Parkinson's & Movement disorders
Mar 04, 2013 |
5 / 5 (2) |
1
|
Elan moves to deter takeover bid
(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.
Other
Mar 04, 2013 |
not rated yet |
0
Study identifies growth factor essential to the most common malignant pediatric brain tumor
A multi-institutional team led by Massachusetts General Hospital (MGH) researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common ...
Cancer
Feb 28, 2013 |
not rated yet |
0
|
Mutation location is the key to prognosis
The three most important factors in real estate are location, location, location, and the same might be said for mutations in the gene MECP2, said researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological ...
Genetics
Feb 28, 2013 |
3 / 5 (1) |
0
|
